Literature DB >> 2493443

In vitro synthesis of a lipid-linked trisaccharide involved in synthesis of enterobacterial common antigen.

K Barr1, P Nunes-Edwards, P D Rick.   

Abstract

The heteropolysaccharide chains of enterobacterial common antigen (ECA) are made up of linear trisaccharide repeat units with the structure----3)-alpha-D-Fuc4NAc-(1----4)- beta-D-ManNAcA-(1----4)-alpha-D-GlcNAc-(1----, where Fuc4NAc is 4-acetamido-4,6-dideoxy-D-galactose, ManNAcA is N-acetyl-D-mannosaminuronic acid, and GlcNAc is N-acetyl-D-glucosamine. The assembly of these chains involves lipid-linked intermediates, and both GlcNAc-pyrophosphorylundecaprenol (lipid I) and ManNAcA-GlcNAc-pyrophosphorylundecaprenol (lipid II) are intermediates in ECA biosynthesis. In this study we demonstrated that lipid II serves as the acceptor of Fuc4NAc residues in the assembly of the trisaccharide repeat unit of ECA chains. Incubation of Escherichia coli membranes with UDP-GlcNAc, UDP-[14C]ManNAcA, and TDP-[3H]Fuc4NAc resulted in the synthesis of a radioactive glycolipid (lipid III) that contained both [14C]ManNAcA and [3H]Fuc4NAc. The oligosaccharide moiety of lipid III was identified as a trisaccharide by gel-permeation chromatography, and the in vitro synthesis of lipid III was dependent on prior synthesis of lipids I and II. Accordingly, the incorporation of [3H]Fuc4NAc into lipid III from the donor TDP-[3H]Fuc4NAc was dependent on the presence of both UDP-GlcNAc and UDP-ManNAcA in the reaction mixtures. In addition, the in vitro synthesis of lipid III was abolished by tunicamycin. Direct conversion of lipid II to lipid III was demonstrated in two-stage reactions in which membranes were initially incubated with UDP-GlcNAc and UDP-[14C]ManNAcA to allow the synthesis of radioactive lipid II. Subsequent addition of TDP-Fuc4Nac to the washed membranes resulted in almost complete conversion of radioactive lipid II to lipid III. The in vitro synthesis of lipid III was also accompanied by the apparent utilization of this lipid intermediate for the assembly of ECA heteropolysaccharide chains. Incubation of membranes with UDP-[3H]GlcNAc, UDP-ManNAcA, and TDP-Fuc4NAc resulted in the apparent incorporation of isotope into ECA polymers, as determined by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and fluorography. In addition, the in vitro incorporation of [3H]Fuc4NAc into ECA heteropolysaccharide chains was demonstrated with ether-treated cells that were prepared from delta rfbA mutants of Salmonella typhimurium. These mutants are defective in the synthesis of TDP-Fuc4NAc; as a consequence, they are also defective in the synthesis of lipid III and they accumulate lipid II. Accordingly, incubation of ether-permeabilized cells of delta rfbA mutants with TDP-[3h]Fuc4NAc resulted in the incorporation of isotope into both lipid III and ECA heteropolysaccharide chains.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2493443      PMCID: PMC209749          DOI: 10.1128/jb.171.3.1326-1332.1989

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  24 in total

1.  Studies on the production of glycolipide by Pseudomonas aeruginosa.

Authors:  G HAUSER; M L KARNOVSKY
Journal:  J Bacteriol       Date:  1954-12       Impact factor: 3.490

Review 2.  Chemistry and biology of the enterobacterial common antigen (ECA).

Authors:  H Mayer; G Schmidt
Journal:  Curr Top Microbiol Immunol       Date:  1979       Impact factor: 4.291

3.  Biosynthesis of enterobacterial common antigen in Escherichia coli. In vitro synthesis of lipid-linked intermediates.

Authors:  K Barr; P D Rick
Journal:  J Biol Chem       Date:  1987-05-25       Impact factor: 5.157

4.  Direction of chain growth in polysaccharide synthesis.

Authors:  P W Robbins; D Bray; B M Dankert; A Wright
Journal:  Science       Date:  1967-12-22       Impact factor: 47.728

5.  Isolation and characterization of a temperature-sensitive lethal mutant of Salmonella typhimurium that is conditionally defective in 3-deoxy-D-manno-octulosonate-8-phosphate synthesis.

Authors:  P D Rick; D A Young
Journal:  J Bacteriol       Date:  1982-05       Impact factor: 3.490

6.  The enzymic synthesis of thymidine-linked sugars. I. Thymidine diphosphate glucose.

Authors:  S KORNFELD; L GLASER
Journal:  J Biol Chem       Date:  1961-06       Impact factor: 5.157

7.  Characterization of an Escherichia coli rff mutant defective in transfer of N-acetylmannosaminuronic acid (ManNAcA) from UDP-ManNAcA to a lipid-linked intermediate involved in enterobacterial common antigen synthesis.

Authors:  K Barr; S Ward; U Meier-Dieter; H Mayer; P D Rick
Journal:  J Bacteriol       Date:  1988-01       Impact factor: 3.490

8.  Biosynthesis of enterobacterial common antigen.

Authors:  P D Rick; H Mayer; B A Neumeyer; S Wolski; D Bitter-Suermann
Journal:  J Bacteriol       Date:  1985-05       Impact factor: 3.490

9.  Modification of the lipid moiety of the enterobacterial common antigen by the "Pseudomonas factor".

Authors:  H M Kuhn; E Neter; H Mayer
Journal:  Infect Immun       Date:  1983-05       Impact factor: 3.441

10.  Biosynthesis of enterobacterial common antigen requires dTDPglucose pyrophosphorylase determined by a Salmonella typhimurium rfb gene and a Salmonella montevideo rfe gene.

Authors:  H C Lew; P H Mäkelä; H M Kuhn; H Mayer; H Nikaido
Journal:  J Bacteriol       Date:  1986-11       Impact factor: 3.490

View more
  10 in total

1.  O acetylation of the enterobacterial common antigen polysaccharide is catalyzed by the product of the yiaH gene of Escherichia coli K-12.

Authors:  Junko Kajimura; Arifur Rahman; James Hsu; Matthew R Evans; Kevin H Gardner; Paul D Rick
Journal:  J Bacteriol       Date:  2006-08-25       Impact factor: 3.490

2.  Localization of enterobacterial common antigen immunoreactivity in the ribosomal cytoplasm of Escherichia coli cells cryosubstituted and embedded at low temperature.

Authors:  G Acker; C Kammerer
Journal:  J Bacteriol       Date:  1990-02       Impact factor: 3.490

3.  Assembly of cyclic enterobacterial common antigen in Escherichia coli K-12.

Authors:  Junko Kajimura; Arifur Rahman; Paul D Rick
Journal:  J Bacteriol       Date:  2005-10       Impact factor: 3.490

4.  Identification of the structural gene for the TDP-Fuc4NAc:lipid II Fuc4NAc transferase involved in synthesis of enterobacterial common antigen in Escherichia coli K-12.

Authors:  A Rahman; K Barr; P D Rick
Journal:  J Bacteriol       Date:  2001-11       Impact factor: 3.490

5.  Identification and biosynthesis of cyclic enterobacterial common antigen in Escherichia coli.

Authors:  Paul J A Erbel; Kathleen Barr; Ninguo Gao; Gerrit J Gerwig; Paul D Rick; Kevin H Gardner
Journal:  J Bacteriol       Date:  2003-03       Impact factor: 3.490

6.  The modality of enterobacterial common antigen polysaccharide chain lengths is regulated by o349 of the wec gene cluster of Escherichia coli K-12.

Authors:  K Barr; J Klena; P D Rick
Journal:  J Bacteriol       Date:  1999-10       Impact factor: 3.490

7.  A genome-wide screen for bacterial envelope biogenesis mutants identifies a novel factor involved in cell wall precursor metabolism.

Authors:  Catherine Paradis-Bleau; George Kritikos; Katya Orlova; Athanasios Typas; Thomas G Bernhardt
Journal:  PLoS Genet       Date:  2014-01-02       Impact factor: 5.917

8.  ElyC and Cyclic Enterobacterial Common Antigen Regulate Synthesis of Phosphoglyceride-Linked Enterobacterial Common Antigen.

Authors:  Joseph F Carr; David E Bautista; Ashutosh K Rai; Wei Wang; Angela M Mitchell
Journal:  mBio       Date:  2021-11-23       Impact factor: 7.867

Review 9.  Enterobacterial Common Antigen: Synthesis and Function of an Enigmatic Molecule.

Authors:  Ashutosh K Rai; Angela M Mitchell
Journal:  mBio       Date:  2020-08-11       Impact factor: 7.867

10.  Cyclic Enterobacterial Common Antigen Maintains the Outer Membrane Permeability Barrier of Escherichia coli in a Manner Controlled by YhdP.

Authors:  Angela M Mitchell; Tharan Srikumar; Thomas J Silhavy
Journal:  mBio       Date:  2018-08-07       Impact factor: 7.867

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.